A Phase I Trial of Dose Escalation of Metformin in Combination with Vincristine, Irinotecan, and Temozolomide in Children with Relapsed or Refractory Solid Tumors
Principal Investigator
Thompson, Patrick
Protocol No.
MCC-16962
Disease Sites
Brain and Nervous System
Breast
Breast - Male
Cervix Uteri
Colon
Corpus Uteri
Esophagus
Eye and Orbit
Kidney
Larynx
Lip, Oral Cavity and Pharynx
Liver
Lung
Melanoma, Skin
Ovary
Pancreas
Prostate
Rectum
Small Intestine
Soft Tissue
Stomach
Thyroid
Urinary Bladder
Phase
Phase I
Contact Info
Email for more information
Or Call 877-668-0683
Participating Sites
UNC-CH
ClinicialTrials.gov
Visit ClinicalTrials.gov for full clinical trial description